These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 27119620)

  • 1. Fibroblast growth factor 21 (FGF21) therapy attenuates left ventricular dysfunction and metabolic disturbance by improving FGF21 sensitivity, cardiac mitochondrial redox homoeostasis and structural changes in pre-diabetic rats.
    Tanajak P; Sa-Nguanmoo P; Wang X; Liang G; Li X; Jiang C; Chattipakorn SC; Chattipakorn N
    Acta Physiol (Oxf); 2016 Aug; 217(4):287-99. PubMed ID: 27119620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparisons of cardioprotective efficacy between fibroblast growth factor 21 and dipeptidyl peptidase-4 inhibitor in prediabetic rats.
    Tanajak P; Sa-Nguanmoo P; Apaijai N; Wang X; Liang G; Li X; Jiang C; Chattipakorn SC; Chattipakorn N
    Cardiovasc Ther; 2017 Aug; 35(4):. PubMed ID: 28391633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vildagliptin and caloric restriction for cardioprotection in pre-diabetic rats.
    Tanajak P; Pintana H; Siri-Angkul N; Khamseekaew J; Apaijai N; Chattipakorn SC; Chattipakorn N
    J Endocrinol; 2017 Feb; 232(2):189-204. PubMed ID: 27875248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGF21 improves cognition by restored synaptic plasticity, dendritic spine density, brain mitochondrial function and cell apoptosis in obese-insulin resistant male rats.
    Sa-Nguanmoo P; Tanajak P; Kerdphoo S; Satjaritanun P; Wang X; Liang G; Li X; Jiang C; Pratchayasakul W; Chattipakorn N; Chattipakorn SC
    Horm Behav; 2016 Sep; 85():86-95. PubMed ID: 27566237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FGF21 and DPP-4 inhibitor equally prevents cognitive decline in obese rats.
    Sa-Nguanmoo P; Tanajak P; Kerdphoo S; Jaiwongkam T; Wang X; Liang G; Li X; Jiang C; Pratchayasakul W; Chattipakorn N; Chattipakorn SC
    Biomed Pharmacother; 2018 Jan; 97():1663-1672. PubMed ID: 29793329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic treatment with prebiotics, probiotics and synbiotics attenuated cardiac dysfunction by improving cardiac mitochondrial dysfunction in male obese insulin-resistant rats.
    Tunapong W; Apaijai N; Yasom S; Tanajak P; Wanchai K; Chunchai T; Kerdphoo S; Eaimworawuthikul S; Thiennimitr P; Pongchaidecha A; Lungkaphin A; Pratchayasakul W; Chattipakorn SC; Chattipakorn N
    Eur J Nutr; 2018 Sep; 57(6):2091-2104. PubMed ID: 28608320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone Deprivation Aggravates Left-Ventricular Dysfunction in Male Obese Insulin-Resistant Rats via Impairing Cardiac Mitochondrial Function and Dynamics Proteins.
    Apaiajai N; Chunchai T; Jaiwongkam T; Kerdphoo S; Chattipakorn SC; Chattipakorn N
    Gerontology; 2018; 64(4):333-343. PubMed ID: 29566382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased plasma FGF21 level as an early biomarker for insulin resistance and metabolic disturbance in obese insulin-resistant rats.
    Tanajak P; Pongkan W; Chattipakorn SC; Chattipakorn N
    Diab Vasc Dis Res; 2018 May; 15(3):263-269. PubMed ID: 29424246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone deprivation accelerates cardiac dysfunction in obese male rats.
    Pongkan W; Pintana H; Sivasinprasasn S; Jaiwongkam T; Chattipakorn SC; Chattipakorn N
    J Endocrinol; 2016 Jun; 229(3):209-20. PubMed ID: 27000685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PCSK9 inhibitor effectively attenuates cardiometabolic impairment in obese-insulin resistant rats.
    Amput P; Palee S; Arunsak B; Pratchayasakul W; Kerdphoo S; Jaiwongkam T; Chattipakorn SC; Chattipakorn N
    Eur J Pharmacol; 2020 Sep; 883():173347. PubMed ID: 32650007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of myeloid differentiation factor 2 attenuates cardiometabolic impairments via reducing cardiac mitochondrial dysfunction, inflammation, apoptosis and ferroptosis in prediabetic rats.
    Sumneang N; Oo TT; Singhanat K; Maneechote C; Arunsak B; Nawara W; Pratchayasakul W; Benjanuwattra J; Apaijai N; Liang G; Chattipakorn SC; Chattipakorn N
    Biochim Biophys Acta Mol Basis Dis; 2022 Feb; 1868(2):166301. PubMed ID: 34748903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of exercise and calorie restriction exerts greater efficacy on cardioprotection than monotherapy in obese-insulin resistant rats through the improvement of cardiac calcium regulation.
    Palee S; Minta W; Mantor D; Sutham W; Jaiwongkam T; Kerdphoo S; Pratchayasakul W; Chattipakorn SC; Chattipakorn N
    Metabolism; 2019 May; 94():77-87. PubMed ID: 30796936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of vildagliptin versus sitagliptin, on cardiac function, heart rate variability and mitochondrial function in obese insulin-resistant rats.
    Apaijai N; Pintana H; Chattipakorn SC; Chattipakorn N
    Br J Pharmacol; 2013 Jul; 169(5):1048-57. PubMed ID: 23488656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial dynamic modulation exerts cardiometabolic protection in obese insulin-resistant rats.
    Maneechote C; Palee S; Apaijai N; Kerdphoo S; Jaiwongkam T; Chattipakorn SC; Chattipakorn N
    Clin Sci (Lond); 2019 Dec; 133(24):2431-2447. PubMed ID: 31808509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vagus Nerve Stimulation Improves Cardiac Function by Preventing Mitochondrial Dysfunction in Obese-Insulin Resistant Rats.
    Samniang B; Shinlapawittayatorn K; Chunchai T; Pongkan W; Kumfu S; Chattipakorn SC; KenKnight BH; Chattipakorn N
    Sci Rep; 2016 Feb; 6():19749. PubMed ID: 26830020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen deprivation aggravates cardiometabolic dysfunction in obese-insulin resistant rats through the impairment of cardiac mitochondrial dynamics.
    Minta W; Palee S; Mantor D; Sutham W; Jaiwongkam T; Kerdphoo S; Pratchayasakul W; Kumfu S; Chattipakorn SC; Chattipakorn N
    Exp Gerontol; 2018 Mar; 103():107-114. PubMed ID: 29331535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Necrostatin-1 reduces cardiac and mitochondrial dysfunction in prediabetic rats.
    Apaijai N; Jinawong K; Singhanat K; Jaiwongkam T; Kerdphoo S; Chattipakorn SC; Chattipakorn N
    J Endocrinol; 2021 Aug; 251(1):27-39. PubMed ID: 34265741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obese-insulin resistance accelerates and aggravates cardiometabolic disorders and cardiac mitochondrial dysfunction in estrogen-deprived female rats.
    Sivasinprasasn S; Sa-Nguanmoo P; Pratchayasakul W; Kumfu S; Chattipakorn SC; Chattipakorn N
    Age (Dordr); 2015; 37(2):28. PubMed ID: 25791519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-allulose provides cardioprotective effect by attenuating cardiac mitochondrial dysfunction in obesity-induced insulin-resistant rats.
    Pongkan W; Jinawong K; Pratchayasakul W; Jaiwongkam T; Kerdphoo S; Tokuda M; Chattipakorn SC; Chattipakorn N
    Eur J Nutr; 2021 Jun; 60(4):2047-2061. PubMed ID: 33011844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of garlic extract on cardiac function, heart rate variability, and cardiac mitochondria in obese insulin-resistant rats.
    Supakul L; Pintana H; Apaijai N; Chattipakorn S; Shinlapawittayatorn K; Chattipakorn N
    Eur J Nutr; 2014 Apr; 53(3):919-28. PubMed ID: 24142245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.